Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive factors for response and for resistance to tyrosine kinase inhibitor therapy in lung cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 May 2007

Cappuzzo Federico

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor
Share to Drug Resistance, Neoplasm
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Forecasting

Share to Genes, erbB-1

Share to Genes, erbB-2

Share to Genes, ras

Source

Identifiers

PMID: 17457222
DOI: 10.1097/01.JTO.0000268634.17956.5e

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive factors for response and for resistance to tyrosine kinase inhibitor therapy in lung cancer.PMID 17457222Read ↗

Role of epidermal growth factor receptor mutations in predicting sensitivity or resistance to targeted agents in non-small-cell lung cancer.Semantic proximity Read ↗

EGFR mutations in non-small cell lung carcinomas may predict response to gefitinib: extension of an emerging paradigm.Semantic proximity Read ↗

Prognostic and predictive biomarkers in lung cancer. A review.Semantic proximity Read ↗

Non-small cell lung cancer - genetic predictorsSemantic proximity Read ↗

Predictors of biomarkers guiding targeted therapeutic strategies in locally advanced lung cancer.Semantic proximity Read ↗

Molecular prognostication of non-small cell lung cancer.Semantic proximity Read ↗

The importance of molecular profiling in predicting response to epidermal growth factor receptor family inhibitors in non-small-cell lung cancer: focus on clinical trial results.Semantic proximity Read ↗

Lung cancer profiling: Genetic and molecular predictors of MEK-dependence.Semantic proximity Read ↗

Epidermal growth factor receptor mutations in non-small cell lung cancer: predicting clinical response to kinase inhibitors.Semantic proximity Read ↗

Management of Resistance to EGFR TKI-Targeted Therapy of Lung Cancer: Lessons in Monitoring Cancer Evolution.Semantic proximity Read ↗

Predictors of sensitivity and resistance to epidermal growth factor receptor inhibitors.Semantic proximity Read ↗

Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.